LSA
DAWN

Leonteq Securities AG’s Day One Biopharmaceuticals DAWN Stock Holding History

Leonteq Securities AG’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-700
Closed -$8.36K – 1219
2023
Q2 		$8.36K Hold
700
– – ﹤0.01% 1063
2023
Q1 		$9.36K Buy
700
+350
+100% +$6.84K ﹤0.01% 1035
2022
Q4 		$7.53K Buy
+350
New +$7.18K ﹤0.01% 1098

Other funds holding DAWN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
CPX
Canaan Partners XI Menlo Park, California $127M AUM 217.49% 1-Year Est. Return

Leonteq Securities AG's DAWN Position: Q3 2023 in Review

Leonteq Securities AG sold out of Day One Biopharmaceuticals (DAWN) in Q3 2023, closing a stake of 700 shares — an estimated $8.36K sold.

Leonteq Securities AG first reported a position in DAWN in Q4 2022 and held it in 3 quarters. The position peaked at $9.36K in Q1 2023. 130 funds tracked by Wall St. Rank hold DAWN as of Q3 2023.

  • Leonteq Securities AG reported no remaining Day One Biopharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • Leonteq Securities AG sold 700 Day One Biopharmaceuticals shares in Q3 2023, an estimated $8.36K.
  • Leonteq Securities AG first reported a position in Day One Biopharmaceuticals in Q4 2022 and held it in 3 quarters.
  • Leonteq Securities AG's Day One Biopharmaceuticals position peaked at $9.36K in Q1 2023.
  • 130 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q3 2023.

Based on Leonteq Securities AG's 13F filing for Q3 2023, filed 11 Mar 2026.